CoChat

Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis

Plutzky, J., Garber, A., Falahati, A., Toft, A.D., Poulter, N.R. · 2009 · Canadian Journal of Diabetes

The DOI matches its Crossref record.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1499-2671(09)33072-5

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 36

Metadata

Authors
Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R.
Affiliations
  • Brigham and Women's Hospital (US)
  • Baylor College of Medicine (US)
  • Novo Nordisk (Denmark) (DK)
  • Imperial College London (GB)
Venue
Canadian Journal of Diabetes
Publisher
Elsevier BV
Published
2009
Volume
33
Issue
3
Pages
209-210
ISSN
1499-2671 (ISSN-L)
OpenAlex
W2059523942
Cited by
33
References
0
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 7 · 2016: 2
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Canadian Journal of Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords
liraglutide, type 2 diabetes, GLP-1 receptor agonists, lipid profile, cardiovascular risk markers, HbA1c, weight loss, systolic blood pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. https://app.cochat.ai/papers/10.1016/s1499-2671(09)33072-5
The paper
Plutzky, J., Garber, A., Falahati, A., Toft, A. D., & Poulter, N. R. (2009). Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis. Canadian Journal of Diabetes. https://doi.org/10.1016/s1499-2671(09)33072-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.